Cavidi
Exazym® — Our breakthrough solution for ultra-sensitive biomarker detection
Cavidi (Uppsala, Sweden) is the company behind Exazym®, which solves a critical research challenge: ultra-sensitive detection of low-abundance biomarkers. Powered by our patented BOLD (Binding Oligo Ladder Detection) technology, Exazym® enables ultra-sensitive biomarker detection by amplifying immunoassay signals up to 100x with minimal background noise. This allows researchers in academic labs, biotech companies, CROs, and hospitals to detect biomarkers at sensitivity levels previously unattainable—cardiac troponins, Alzheimer’s biomarkers and cytokines.
Exazym® works seamlessly within existing immunoassay protocols, empowering researchers to unlock discoveries in biomarker research, drug development, and clinical diagnostics. Exazym Kits are available online and through global distributors. For volume pricing or custom solutions, contact our sales team.
About Cavidi
Cavidi is a Swedish biotech company specializing in ultra-sensitive biomarker detection. With 40 years of virology and diagnostics expertise, we developed BOLD (Binding Oligo Ladder Detection) – our patented signal-amplification technology that powers Exazym® – fundamentally changing what’s possible in precision diagnostics.
Today, Cavidi is democratizing precision diagnostics by making ultra-sensitive, reliable detection accessible globally. Our mission is to fuel advancement in healthcare by providing researchers and clinicians greater access to precision diagnostics. We believe the best tests offer both high accuracy and widespread access.
Learn more about Exazym
Follow Cavidi
Contact Cavidi
Address: Cavidi AB, Virdings Allé 2, 754 50 Uppsala, Sweden
Phone: +46 18 55 20 40